AtriCure Current Valuation vs. Cash Flow From Operations
| ATRC Stock | USD 29.85 0.31 1.05% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.58 | 0.7441 |
|
|
The module aggregates profitability drivers for AtriCure with ratios tied to revenue, assets, and equity.
Trending Equities. Macro event markers
Earnings Share -0.24 | Revenue Per Share | Quarterly Revenue Growth 0.131 | Return On Assets | Return On Equity |
Investors evaluate AtriCure using market value and book value, each describing different facets of the business. AtriCure's market capitalization is 1.49 B. A P/B ratio of 2.99 indicates the market values AtriCure above its accounting book value. Enterprise value stands at 1.38 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for AtriCure differs from its quoted price, since each reflects a different lens. For AtriCure, key inputs include a P/E ratio of 33.47, a P/B ratio of 2.99, a profit margin of -2.14%, and ROE of -2.4%. Trading price represents the transaction level agreed by market participants.
AtriCure Cash Flow From Operations vs. Current Valuation Fundamental Analysis
Sector multiples frame AtriCure's current valuation context. AtriCure holds the #5 position for current valuation relative to top peers. It is rated below average for cash flow from operations relative to top peers with a Cash Flow From Operations-to-Current Valuation ratio near 0.04 . The Current Valuation to Cash Flow From Operations ratio for AtriCure comes in at 24.01 . Relative ratio analysis evaluates AtriCure's earnings valuation.AtriCure's Historical Earnings Breakdown by Geography
AtriCure Current Valuation vs. Competition
AtriCure holds the #5 position for current valuation relative to top peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 20.15 Billion. AtriCure holds roughly 1.38 Billion in current valuation claiming about 7% of equities under Health Care sector.
AtriCure Cash Flow From Operations vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
AtriCure |
| = | 1.38 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
AtriCure |
| = | 57.33 M |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
AtriCure Cash Flow From Operations Comparison
AtriCure is currently under evaluation for cash flow from operations relative to top peers.
AtriCure Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AtriCure, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AtriCure will eventually generate negative long term returns. The profitability progress is the general direction of AtriCure's change in net profit over the period of time. It can combine multiple indicators of AtriCure, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 566 K | 594.3 K | |
| Operating Income | -3.4 M | -3.6 M | |
| Total Other Income Expense Net | -6.7 M | -6.4 M | |
| Net Loss | -11.4 M | -12 M | |
| Income Tax Expense | 1.3 M | 874.8 K | |
| Income Before Tax | -10.2 M | -10.7 M | |
| Net Loss | -11.4 M | -12 M | |
| Non Operating Income Net Other | 1.7 M | 1.8 M | |
| Net Loss | -41.8 M | -39.7 M | |
| Interest Income | 4.5 M | 4.7 M | |
| Net Interest Income | -1.4 M | -1.5 M | |
| Change To Netincome | 26.6 M | 27.9 M | |
| Net Loss | -0.24 | -0.25 | |
| Income Quality | -5.76 | -5.47 | |
| Net Income Per E B T | 1.13 | 0.81 |
AtriCure Profitability Driver Comparison
Understanding AtriCure's profitability drivers is a critical part of evaluating AtriCure as an investment. Unexpected events - from regulatory changes to commodity price movements - can materially alter the profit trajectory and investment outlook during any given holding period.
Earnings per Share Projection vs Actual
Use AtriCure in pair-trading
Pair trading with AtriCure can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
AtriCure Pair Trading
AtriCure Pair Trading Analysis
Identifying correlated replacements for AtriCure is particularly important in concentrated portfolios where AtriCure represents a large allocation. A poor substitute could introduce unintended factor or sector risks that persist beyond the required waiting period.
Correlation is not causation, but for AtriCure it is a practical tool. High correlations between AtriCure and a potential addition to the portfolio flag concentrated exposure, while low correlations signal diversification potential.
Correlation analysis and pair evaluation for AtriCure can support hedging context. The method can be applied across sectors and broader equity sets.Use Investing Themes to Complement your AtriCure position
Using AtriCure inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Did You Try This Idea?
Run Marketing Thematic Idea Now
Marketing
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
| View All Next | Launch |
More Resources for AtriCure Stock Analysis
Reviewing AtriCure commonly begins with financial statements and performance trends. Financial ratios provide context for profitability, efficiency, and growth trends. Selected reports below provide context for AtriCure Stock:Trending Equities. Our How to Buy AtriCure Stock guide explains the steps to invest in AtriCure stock.Analysis related to AtriCure should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Holdings module to check your current holdings and cash position to determine if your portfolio needs rebalancing.
A projection view for AtriCure starts with historical financial statements. The core view includes income statement, balance sheet, and cash flow.